Navigation Links
Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18

a in situ (AIS)), cervical pre-cancers (cervical intraepithelial neoplasia (CIN) grade 2), vulvar pre-cancers (vulvar intraepithelial neoplasia (VIN) 2/3) and vaginal pre-cancers (vaginal intraepithelial neoplasia (VaIN) 2/3), and for the prevention of genital warts and low-grade cervical lesions (CIN 1) caused by HPV types 6, 11, 16 and 18. GARDASIL is contraindicated in individuals who are hypersensitive to the active substances or to any of the excipients of the vaccine.

High grade vulvar and vaginal lesions indicators for possible development of cancer

The studies used for this analysis combine findings from one phase II study and two phase III studies - Protocol 007, Protocol 013 (FUTURE I) and Protocol 015 (FUTURE II), respectively. All three studies were double-blind, placebo-controlled randomized studies and were conducted at 157 sites in 24 countries. More than 18,000 women participated in the three trials and were between the ages of 16 to 26 at the time of enrollment. They received three doses of either GARDASIL or placebo at day one, month two and month six. The combined analysis evaluated the impact of GARDASIL on the incidence of high-grade vulvar and vaginal pre-cancers (VIN 2/3 and VaIN 2/3), common precursors to vulvar and vaginal cancers in younger women, caused by HPV types 16 and 18.

In the per-protocol population of this combined analysis, GARDASIL was 100 percent effective in preventing HPV 16- and 18-related VIN 2/3 and VaIN 2/3 in women who were not exposed to the relevant HPV types until at least one month after completing the vaccination series; no cases were observed in the vaccine group (n=7,811) compared to 15 cases in the placebo group (n=7,785).

In the unrestricted population of this combined analysis, GARDASIL was 97 percent effective in preventing HPV 16- and 18-related VIN 2/3 and VaIN 2/3 in women who may have been exposed to the relevant HPV types before completing the vaccination series; one case was o
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
2. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
3. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
4. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
5. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
6. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
7. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
8. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
9. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
10. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
11. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression

Post Your Comments:
(Date:11/7/2009)...re/ -- Patients reported C1-esterase inhibitor (C1...ing acute swelling attacks at any body location fo...ing to data presented today at the 2009 American C... Annual Meeting. The results come from a self-repo... the ongoing, prospective, open label I nternatio...
(Date:11/6/2009)...Call/ -- Recession in domestic and international m...hcare Products in the first quarter of fiscal year...nes pushed Allied into a loss for the quarter. Th...negative 9 cents per share, compared to a net prof...per share. ,, Sales fell about 21 percent in t...
(Date:11/6/2009)...e-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE...ny, announced today that Paul Bisaro, Watson,s pre...n overview and update of the Company,s business at...ce on Wednesday, November 11, 2009 at 12:00 pm Eas...e webcast live and can be accessed on Watson Pharm...
Breaking Medicine Technology:Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6Computer modeling shows strategies to rein in epidemics need to be retooled for rural populations 47653 1Computer modeling shows strategies to rein in epidemics need to be retooled for rural populations 47653 2Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations 47649 1Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations 47649 2Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations 47649 3Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of Take Charge Workshops for the Unemployed 12423 1Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of Take Charge Workshops for the Unemployed 12423 2Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of Take Charge Workshops for the Unemployed 12423 3Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of Take Charge Workshops for the Unemployed 12423 4
(Date:11/8/2009)... Nov. 7 Today, the Hous...tur, Dahlkemper, Smith, Ellsworth and Lipinski ame...Act" (H.R. 3962). The amendment maintains the curr...ion and for benefits packages that include abortio...eceive affordability credits and those who do not,...
(Date:11/8/2009)...Swift Passage of H.R. 3961 to Secure the Stability...Newswire/ -- Statement Attributable to: J. James R...on. ,, (Logo: http://www.newscom.com/cgi-bin/... passage of the House health reform bill, which wi... physicians and calls for swift passage of H.R. 39...
(Date:11/8/2009)...Calif., Nov. 8 March of...ies luncheon to recognize prominent individuals wh...who are role models for March of Dimes commitment ...arch of Dimes November Prematurity Awareness Month...ed to join the fight for preemies! ,, (Photo: ...
(Date:11/7/2009)...T. Coleman (CT), David A. Cook (GA), Louis J. Good...A) Honored ,, CHICAGO, Nov. 7 /PRNewswire-USNe...today presented five medical society executive lea...butions to the goals and ideals of the medical pro...mi-annual policy making meeting in Houston. ,,...
(Date:11/7/2009)... Nov. 7 The U.S. bishop...ntatives to vote for the Stupak-Ellsworth Amendmen...sworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amen...ortion funding and conscience protections in the A..." they said. ,, The letter was signed by Cardin...
Breaking Medicine News(10 mins):Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3Health News:AMA Honors Medical Society Executives 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2
...t of Beth Israel Deaconess,Medical Center audit, ...rector Douglas T. Linde should apply the same Sarb... other publicly traded companies to,his role on th... and CFO of Boston Properties., 1199 SEIU asserts...
...,(Amex: FHC ) today announced that it will host a...g results for the first quarter of FY2008 at 11:00..., 2008. The Company plans,to report its first quar...03-6873 (international participants dial,973-582-2...
...t of Beth Israel Deaconess,Medical Center audit, ... Robert Lepofsky should apply the same Sarbanes-Ox...aded companies to his role as Vice,Chairperson of ...Workers East., 1199 SEIU asserts that board membe...
...rt,to make tangible improvements in the health of ...ed for 10 a.m. today in the State Capitol,s Blue,R...t in Oklahoma,s rates of,early childhood immunizat...n,for rates of early childhood immunizations (age ...
...ON, Feb. 6 Patient-Centered Computing,and eHealth...e and timely,course that will be presented under t...f Continuing Education. The course, which will be ...throughout the United States, and abroad., Throug...
...man . , Scientists from the University of Bonn ... have lived off more than 100 million years ago. T...o become as large as they did. In actual fact such... Take 200 milligrammes of dried and ground equiset...
Other Medicine News:Health News:Boston Properties Executive and Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU 2Health News:The Female Health Company Schedules First Quarter Conference Call for February 13, 2008 2Health News:Brooks Automation Executive and Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU 2Health News:State Leaders Recognize Oklahoma's Improvement in Immunization Rankings 2Health News:Innovative eHealth Course to Take Place March 28-30 in Boston, Massachusetts 2Health News:Bonn scientists simulate dinosaur digestion in the lab 2Health News:Bonn scientists simulate dinosaur digestion in the lab 3
...the market today. The horseshoe evaporator ensures...rain channels away moisture for continual defrost ...ugh, baked-on epoxy paint finish and the textured ...igerator is constructed of vacuum molded, high-imp...
...pH and temperature measurements. Temperature compe... temperature probe (ATC) or a 3-in-1 electrode. &b...ith Auto-Find automatic buffer recognition for fiv...nd Auto-Read for locking onto stable readings. &bu...
...pH and temperature measurements. Temperature compe... temperature probe (ATC) or a 3-in-1 electrode. &b...ith Auto-Find automatic buffer recognition for fiv...nd Auto-Read for locking onto stable readings. &bu...
...pH and temperature measurements. Temperature compe... temperature probe (ATC) or a 3-in-1 electrode. &b...ith Auto-Find automatic buffer recognition for fiv...nd Auto-Read for locking onto stable readings. &bu...
Medicine Products: